KASL Clinical Practice Guidelines for Management of Chronic Hepatitis B

Overview

Journal Clin Mol Hepatol

Specialty Gastroenterology

Date 2019 Jun 13

PMID 31185710

Citations 77

Affiliations

Soon will be listed here.

Citing Articles

Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysis.

Huang L, Feng L, Lu Y, Hu B, Liang H, Ren A Front Med (Lausanne). 2025; 12:1529201.

PMID: 40061381 PMC: 11885123. DOI: 10.3389/fmed.2025.1529201.

Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients.

Lin W, Lin K, Li M, Liu X, Huang Y, Wang X World J Hepatol. 2024; 16(11):1321-1330.

PMID: 39606169 PMC: 11586753. DOI: 10.4254/wjh.v16.i11.1321.

Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study.

Mihai N, Olariu M, Ganea O, Adamescu A, Molagic V, Arama S J Clin Med. 2024; 13(20).

PMID: 39457983 PMC: 11508539. DOI: 10.3390/jcm13206032.

Kim M, Kim B, Cho H, Goh M, Roh Y, Yu S PLoS One. 2024; 19(8):e0307712.

PMID: 39186715 PMC: 11346930. DOI: 10.1371/journal.pone.0307712.

Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis.

Kim M, An J, Kim E, Kim H, Lee H, Yu J Clin Mol Hepatol. 2024; 30(Suppl):S106-S116.

PMID: 39043361 PMC: 11493358. DOI: 10.3350/cmh.2024.0371.

References

Triantos C, Kalafateli M, Nikolopoulou V, Burroughs A . Meta-analysis: antiviral treatment for hepatitis D. Aliment Pharmacol Ther. 2012; 35(6):663-73. DOI: 10.1111/j.1365-2036.2012.04993.x. View

Yeo W, Johnson P . Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006; 43(2):209-20. DOI: 10.1002/hep.21051. View

Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G . Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B. Liver Transpl. 2013; 19(8):887-95. PMC: 3791551. DOI: 10.1002/lt.23690. View

Chamorro C, Aparicio M . Influence of anti-HBc positive organ donor in lung donor selection. Arch Bronconeumol. 2012; 48(9):320-4. DOI: 10.1016/j.arbres.2012.04.025. View

Markowitz J, MARTIN P, Conrad A, Markmann J, Seu P, Yersiz H . Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998; 28(2):585-9. DOI: 10.1002/hep.510280241. View

Song G, Yang R, Rao H, Feng B, Ma H, Jin Q . Serum HBV core-related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients. J Med Virol. 2016; 89(3):463-468. DOI: 10.1002/jmv.24657. View

Liu W, Wang X, Zheng W, Ping L, Zhang C, Wang G . Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma. Leuk Lymphoma. 2016; 57(6):1355-62. DOI: 10.3109/10428194.2015.1116121. View

Freeman R, Sanchez H, Lewis W, Sherburne B, Dzik W, Khettry U . Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation. 1991; 51(4):793-7. DOI: 10.1097/00007890-199104000-00011. View

Sarin S, Kumar M, Lau G, Abbas Z, Chan H, Chen C . Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2015; 10(1):1-98. PMC: 4722087. DOI: 10.1007/s12072-015-9675-4. View

10.

de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E . The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med. 1993; 118(3):191-4. DOI: 10.7326/0003-4819-118-3-199302010-00006. View

11.

Yeo W, Chan T, Leung N, Lam W, Mo F, Chu M . Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2008; 27(4):605-11. DOI: 10.1200/JCO.2008.18.0182. View

12.

Moon H, Cho J, Hur M, Yun Y, Choe W, Kwon S . Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift. World J Gastroenterol. 2010; 16(9):1115-8. PMC: 2835789. DOI: 10.3748/wjg.v16.i9.1115. View

13.

Papatheodoridis G, Vlachogiannakos I, Cholongitas E, Wursthorn K, Thomadakis C, Touloumi G . Discontinuation of oral antivirals in chronic hepatitis B: A systematic review. Hepatology. 2016; 63(5):1481-92. DOI: 10.1002/hep.28438. View

14.

Liu S, Zhang H, Gu C, Yin J, He Y, Xie J . Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009; 101(15):1066-82. PMC: 2720989. DOI: 10.1093/jnci/djp180. View

15.

Fontana R . Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009; 49(5 Suppl):S185-95. DOI: 10.1002/hep.22885. View

16.

Jeng W, Sheen I, Chen Y, Hsu C, Chien R, Chu C . Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients. Hepatology. 2013; 58(6):1888-96. DOI: 10.1002/hep.26549. View

17.

Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott J . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546-55. DOI: 10.1016/S0140-6736(15)61412-X. View

18.

Stuyver L, Locarnini S, Lok A, Richman D, Carman W, Dienstag J . Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology. 2001; 33(3):751-7. DOI: 10.1053/jhep.2001.22166. View

19.

Craig A, Schaffner W . Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med. 2004; 350(5):476-81. DOI: 10.1056/NEJMcp031540. View

20.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm S, Christensen E . Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol. 2002; 97(11):2886-95. DOI: 10.1111/j.1572-0241.2002.07057.x. View